Feb 26, 2026 04:00PM
Jan 5, 2026 07:00AM
Dec 9, 2025 11:57AM
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Oct 10, 2025 04:00PM
Oct 3, 2025 07:06AM
Aug 28, 2025 07:00AM
Aug 21, 2025 06:22AM
Aug 20, 2025 02:11PM
Aug 20, 2025 01:58PM
Aug 20, 2025 07:00AM FDA lifts clinical hold on Rocket Pharmaceuticals' Danon disease trial
Aug 20, 2025 07:00AM
Aug 8, 2025 05:35AM
Aug 7, 2025 04:00PM
Aug 7, 2025 09:25AM
Jul 29, 2025 03:05PM
Jul 25, 2025 06:14AM
Jul 24, 2025 07:00AM Rocket Pharmaceuticals cuts workforce 30% to focus on heart treatments
Jul 24, 2025 07:00AM
Jul 22, 2025 05:25PM
Jul 22, 2025 03:51PM
Jul 22, 2025 12:38PM
Jul 20, 2025 04:00PM
Jul 19, 2025 08:05AM
Jul 18, 2025 01:07PM INVESTOR REMINDER: Berger Montague Notifies Rocket Pharmaceuticals (RCKT) Investors of a Class Action Lawsuit and Deadline
Jul 18, 2025 12:27PM
Jul 18, 2025 06:15AM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM
Jul 16, 2025 04:16PM
Jul 15, 2025 08:30AM
Jul 14, 2025 05:11PM Investor Alert: Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Trial Safety Concerns
Jul 14, 2025 04:00PM
Jul 14, 2025 12:30PM
Jul 13, 2025 07:59AM
Jul 10, 2025 04:51PM
Jul 9, 2025 02:25PM
Jul 8, 2025 07:08PM
Jul 8, 2025 04:00PM RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 8, 2025 09:10AM
Jul 7, 2025 07:15PM
Jul 7, 2025 09:11AM
Jul 7, 2025 02:30AM
Jul 6, 2025 10:00AM
Jul 5, 2025 08:15AM
Jul 3, 2025 01:21PM Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
Jul 3, 2025 09:10AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All